Skip to Main Content

Author Details

Kelli Gaskins
Frederick National Laboratory for Cancer Research, National Institutes of Health
2014
9
8
PMIDPaper TitleJournal TitlePublished Year
32934779GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3.Oncotarget2020
31937621A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).Clin Cancer Res2020
32934779GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3.Oncotarget2020
31937621A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).Clin Cancer Res2020
29481652Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors.J Natl Cancer Inst2018
30250647Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.Oncotarget2018
29481652Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors.J Natl Cancer Inst2018
29691295Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>.Clin Cancer Res2018
30250647Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.Oncotarget2018
29691295Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>.Clin Cancer Res2018
28600475Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.Clin Cancer Res2017
28600475Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.Clin Cancer Res2017
28114280RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma.Oncogene2017
28114280RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma.Oncogene2017
27336360Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma.J Clin Endocrinol Metab2016
27336360Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma.J Clin Endocrinol Metab2016
24262022An in vivo mouse model of metastatic human thyroid cancer.Thyroid2014
24262022An in vivo mouse model of metastatic human thyroid cancer.Thyroid2014
  • 1 - 18 of 18

Recommended Authors

Wei Zhang
University of Manchester
Career Start Year 2011
Number of shared co-authors 0
Jack Zhu
Center for Cancer Research, National Cancer Institute Bethesda
Career Start Year 2010
Number of shared co-authors 5
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Alan L Ho
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Katayoon Kasaian
Ontario Institute for Cancer Research
Career Start Year 2008
Number of shared co-authors 1
Jennifer R Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 0
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 0
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 1
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 0
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 9
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Kristiina Iljin
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 0
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 0
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Matthew D Ringel
The Ohio State University College of Medicine and Comprehensive Cancer Center
Career Start Year 1991
Number of shared co-authors 2
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 0
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 1
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 5
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 10
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 1
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 1

Collaborators

Electron Kebebew
Stanford University School of Medicine
Co-authored papers 9
Sudheer Kumar Gara
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Lisa Zhang
National Institute of Child Health and Development
Co-authored papers 5
Myriem Boufraqech
The University of Texas at Austin
Co-authored papers 4
Naris Nilubol
Center for Cancer Research
Co-authored papers 3
Dhaval Patel
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Yi Liu-Chittenden
Department of Biochemistry and Howard Hughes Medical Institute, Stanford University
Co-authored papers 2
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Min Shen
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 2
Shweta Kotian
Center for Drug Evaluation and Research
Co-authored papers 2
Shubin Wang
The First Affiliated Hospital of Zhengzhou University
Co-authored papers 1
Thomas J Giordano
University of Michigan ann arbor
Co-authored papers 1
Christopher P Austin
St. George's University Medical School
Co-authored papers 1
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Sheue-Yann Cheng
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 1
Meenu Jain
Georgia Cancer Center, Augusta University
Co-authored papers 1
Sunita K Agarwal
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 1
Release 1.2